ロード中...
lincROR influences the stemness and crizotinib resistance in EML–ALK(+) non-small-cell lung cancer cells
INTRODUCTION: Echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4–ALK) is identified as an important pathogenic factor in patients with non-small-cell lung cancer (NSCLC) and could induce a stem-like phenotype in NSCLC cells. Crizotinib is commonly used for EML4–ALK(+)...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6018841/ https://ncbi.nlm.nih.gov/pubmed/29950868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S165290 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|